ARCHIVES

Blinatumomab Demonstrates High Response Rate in ALL

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Survival For ALL Increased To 94 Percent In Recent Years

December 31, 2010

New Research Grant Awards

December 13, 1974

Advocacy: Friends To Continue Another Year

June 13, 1997

Bush Appoints Kripke To President’s Cancer Panel

February 21, 2003

Women’s Health Initiative Trial Produced $37.1 Billion in Returns

May 9, 2014

In Brief: No Such Thing As Premature Data, Fisher Says- Only Immature Evaluation, Premature Application

June 20, 1980